Obesity Genes, Personalized Medicine, and Public Health Policy

被引：3
作者：
Caulfield T. [1 ]
机构：
[1] Faculty of Law and School of Public Health, 461 Law Centre, University of Alberta, Edmonton, T6G, AB
来源：
Current Obesity Reports | 2015年 / 4卷 / 3期
基金：
加拿大健康研究院;
关键词：
Genetic testing; Law; Obesity policy; Personalized medicine;
D O I：
10.1007/s13679-015-0163-x
中图分类号：
学科分类号：
摘要：
The personalized medicine movement-also known as precision medicine and personalized genomics-has embraced the belief that genetic risk information can be used to motivate healthier choices and meaningful behaviour change. While a genuinely exciting area of research, there are numerous policy issues associated with a focus on the use of genetic risk information to personalize approaches to obesity prevention.
引用
收藏
页码：319 / 323
页数：4
相关论文
共 99 条
[1]  
Lili LN(2014)Evidence for the importance of personalized molecular profiling in pancreatic cancer Pancreas 43 198-513
[2]  
Matyunina LN(2012)Communicating genetic risk information for common disorders in the era of genomic medicine Annu Rev Genomics Hum Genet 14 491-26
[3]  
Walker LD(2015)Integrating big data and actionable health coaching to optimize wellness BMC Med 13 4-206
[4]  
Lautenbach DM(2012)Genetic determinants of common obesity and their value in prediction Best Pract Res Clin Endocrinol Metab 26 211-76
[5]  
Christensen KD(2015)Genetic studies of body mass index yield new insights for obesity biology Nature 518 197-54
[6]  
Sparks JA(2012)Misuse (and abuse?) of the concept of empowerment. The case of online offer of predictive direct-to-consumer genetic tests J Public Health Res 1 7-9
[7]  
Hood L(2013)Whole genome sequencing in support of wellness and health maintenance Genome Med 5 58-45
[8]  
Lovejoy JC(2013)P4 medicine: how systems medicine will transform the healthcare sector and society Pers Med 10 565-75
[9]  
Price ND(2013)Reflections on the cost of “low-cost” whole genome sequencing: framing the health policy debate PLoS Biol 11 e1001699-503
[10]  
Loos RJ(2010)Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours Cochrane Database Syst Rev 10 CD007275-15
12345678910